26-Nov-2007 - The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego.
21-Nov-2007 - A startling breakthrough has allowed scientists to create human stem cells from just reprogrammed skin cells, with no embryo and thus, perhaps no ethical dilemma.
20-Nov-2007 - While India, the Asia-Pacific, Eastern Europe and Latin America are all gaining recognition as potential new hot spots, South Africa remains 'underutilised as a clinical trial destination,' according to a prominent industry figure.
02-Nov-2007 - With IMS Health's annual forecast for the pharma industry predicting slower approvals, more black box warnings and the continuation of the 'wave of genericization,' the shift by pharma firms to refocus and reinvent themselves will need to move on apace in order to secure their position in a changing market.
29-Oct-2007 - Despite often attracting a barrage of negative publicity, particularly in regard to a perception of putting profits before people, big pharma firms are still capable of showing their human side in times of crisis.
22-Oct-2007 - We've all cringed at stories of people dumping their partners via text message but in the world of business, Pfizer seems to have taken things to a new level when its Exubera partners were allegedly left to find out the product was being scrapped through a press release.
08-Oct-2007 - As an increasingly desperate pharma industry strives to fill drug pipelines, the sector has, for the first time, topped a poll of which industries spend the most on research and development.
02-Oct-2007 - The US Food and Drug Administration (FDA) has been called into question again after the release of a damning report, this time suggesting the agency is inadequate in its safety monitoring of clinical trials.
17-Sep-2007 - A group of leading drug developers have set up an international talent network for a 'global assault' on some of the world's deadliest diseases, such as tuberculosis (TB), malaria and AIDS, on a not-for-profit basis.
06-Sep-2007 - Eight months after the debate started over whether hybrid embryo research should be allowed in the UK, the Human Fertilisation and Embryology Authority (HFEA) has given researchers the thumbs up - but only on a case-by-case basis.
30-Aug-2007 - As part of a drive towards greater innovation, the Chinese government looks set to introduce new laws giving its domestic scientists freedom to tackle complex scientific problems without fear of failure, according to a state media report this week.
21-Aug-2007 - The Association of the British Pharmaceutical Industry (ABPI) has now published revised guidelines for Phase I trials in the UK.
14-Aug-2007 - The often cited decline in R&D productivity and dwindling innovation within the pharma industry is actually a thing of the past, according to Wyeth's head of business development.
08-Aug-2007 - Targeted Genetics said it was 'premature as well as irresponsible' to draw any conclusions on what caused the death of a patient who participated in a clinical trial testing the safety of the firm's new gene therapy.
30-Jul-2007 - The UK government has been ordered to review the assessment system it uses to classify and grant permission for animal experiments following a court ruling handed down last week.
18-Jul-2007 - A recent survey of clinical trial participants in the US has revealed worrying signs that the informed consent process is 'not up to scratch'.
10-Jul-2007 - China has wasted no time in executing the first of its convicted corrupt former drug officials after his desperate appeal for life failed.
13-Jun-2007 - The former director of the country's State Food and Drug Administration (SFDA) has lodged an appeal against the death penalty slapped on him after a corruption conviction.
24-Aug-2005 - Vioxx. Bextra. Zyprexa, Seroxat. At no period of time have so many high-profile drugs come under the spotlight as drug companies face legal action over drug safety. It's make or break time for the pharmaceutical industry as drug companies are possibly facing its biggest crisis since the thalidomide fiasco almost fifty years ago.